Overview
Legal name
NEOTHERIX LIMITED
Region
Yorkshire and the Humber
Registered address
25 CARR LANE
YORK
YO26 5HT
Insolvency history
No
Company
Active
LTD
Company profile
Neotherix Limited
Neotherix | Regenerative Soft Tissue Healing and Repair
Neotherix technology uses the bodys ability to repair itself. Our advances in soft tissue repair deliver cells with healing 3D architecture.
CRN
06300637
Founded
2007
Age
19
Corporate ownership
Updated 06 Jun 2026 16:52
Neotherix Limited
No active corporate controller recorded.
Company events
Reference milestones and recent Companies House filing stream events.
5 events
08 Aug
2026
Confirmation statement due
Confirmation DueNext confirmation statement due date
30 Jun
2026
Accounts due
Accounts DueNext accounts due date
25 Jul
2025
Confirmation statement filed
ConfirmationLast confirmation statement made up date
30 Sep
2024
Accounts filed
AccountsLast accounts made up date
03 Jul
2007
Incorporated
InceptionCompany registered at Companies House
Public funding
6 awards
First funded
2008
Funded years
2008, 2010, 2012, 2013, 2015
Age at first award
0 years
Projects
2015
Vouchers
Lead participant
Antibacterial light as a primer for the use of tissue scaffolds in wounds
1 Aug 2015 to 31 Jan 2016
Awarded
£5,000
Total cost £5,000
"Neotherix Ltd is a regenerative medicine company specialising in the development of bioresorbable scaffolds for tissue regeneration and repair. The company has recently developed an interest in the use of specific wavelengths of light at the skin surface for the control of bacterial infections."
2013
GRD Proof of Market
Lead participant
Personalised tissue repair scaffolds: assessment of market and clinical attractiveness
1 Oct 2013 to 30 Jun 2014
Awarded
£14,992
Total cost £24,988
The project proposed in this application has the aim of exploring the attractiveness of a number of demanding technical options for increasing the proportion of the market addressable by Neotherix’ electrospun scaffold technology. We will consider the benefits of seeding the scaffold with autologous cells before administration to the patient and of a syst...
2012
Feasibility Studies
Lead participant
Feasibility of Neotherix electrospun scaffolds with additional anti-cancer functionality for regenerative medicine
1 Aug 2012 to 30 Nov 2012
Awarded
£24,942
Total cost £33,256
Neotherix Limited is a regenerative medicine company developing novel bioresorbable scaffolds for soft tissue repair and regeneration. As the number of applications and technologies for regenerative medicine continue to grow, there will be an increasing demand for functional materials that are capable of carrying out multiple roles during tissue repair. F...
2012
Collaborative R&D
Lead participant
EktoTherix: Initial clinical evaluation of a regenerative tissue scaffold for repair of surgical excision wounds
1 Feb 2012 to 31 Oct 2016
Awarded
£137,869
Total cost £290,128
Neotherix (York UK) has developed the EktoTherix™ bioresorbable scaffold material that assists patient tissue repair and regeneration, with an initial target clinical application of non-melanoma skin cancers (NMSC) with further indications to follow. A patch of the material is used following excision of the basal or squamous carcinoma by the clinician, an...
2010
Fast Track
Lead participant
EktoTherix: translation from R&D of a regenerative tissue scaffold for repair of surgical excision wounds
1 Aug 2010 to 31 Mar 2011
Awarded
£116,558
Total cost £240,386
Awaiting Public Summary
2008
Collaborative R&D
Lead participant
RegeniTherix - smart scaffolds for optimised wound healing
1 Jul 2008 to 30 Jun 2011
Awarded
£164,317
Total cost £328,633
Awaiting Public Summary
Product types
Collaborative R&D
Fast Track
Feasibility Studies
GRD Proof of Market
Vouchers